Otitis Media

Chennai, Dec 18 (UNI) A team of surgeons at Apollo Speciality Hospital OMR performed a first of its kind, rare surgery on a 54-year-old man, who was suffering from a condition where a part of his brain was oozing out through a hole in the ear. The patient, Loganathan, an auditor in a private company in Erode, was suffering from severe periodical headaches and right ear pain/block for the past one year. Though he visited several hospitals, the reason for his head or ear ache could not be diagnosed. One of the hospitals even performed a tympanomastoidectomy for Right Chronic Otitis media considering this as an ear infection. Few months later, he started developing further complications, including a clear watery discharge from his right ear, besides persistent headache. https://ift.tt/2SQ7ZPY

When the ear aches in children fiercely, it’s probably an acute inflammation of the middle ear. Chronic – i.e. permanent – ear infections plague more adults. They differ significantly from the acute Form. “In the chronic Form, the mucous membranes of the middle ear are inflamed and long-lasting,” says Andreas Gerstner, chief physician of the clinic for ear, nose and throat medicine in Brunswick. “In addition, a permanent hole in the eardrum.” How the chronic inflammation of the middle ear can detect? The guile of chronic otitis media: The most painful ear piercing, the features of the acute inflammation, does not occur in the rule. “A note can be permanently Secretions running from the ear,” says Jens Peter Klußmann, Director and chair of the clinic for ear, nose and throat medicine at the University of Cologne. “Often, Hearing is getting worse.” Why Doctors recommend a surgery? the ENT doctor a chronic inflammation of the middle ear, is often a surgery is advisable. The hole i...

IRVINE, Calif.--(BUSINESS WIRE)--Dec 4, 2018--Novus Therapeutics, Inc. (NASDAQ: NVUS), a specialty pharmaceutical company focused on developing products for patients with disorders of the ear, nose, and throat (ENT), today announced the formation of a new Scientific Advisory Board (SAB), which is comprised of international experts in otolaryngology, pediatrics, and infectious diseases. The SAB will work closely with the Novus management team to advance OP0201, the company’s lead product candidate being developed for otitis media. “We are honored to have such a highly distinguished team of experts join our newly formed scientific advisory board,” said Dr. Catherine Turkel, President of Novus Therapeutics. “This group of seasoned clinicians and researchers have extensive backgrounds in otitis media and will be instrumental as we advance OP0201 through clinical development. We look forward to working with them over the coming years.” Members of the Novus SAB include: Hamid Djalilian,...